Pre-treatment of the beta3-adrenergic receptor agonist BRL37344 reduces in vivo myocardial ischemia/reperfusion injury by improving AMPK and SIRT1 activity and by suppressing mTOR... অনুযায়ী Dilan Askin Ozek, Elif Onat, Kazim Sahin, Mehmet Tuzcu, Merve Yilmaz Bozoglan, Engin Sahna

সম্পূর্ণ পাঠ পাওয়ার জন্য